Opioid Overdose

Opioid overdose is poisoning by opioid agonists — whether prescription analgesics, heroin, or illicitly manufactured fentanyls — characterized by the classic triad of depressed consciousness, depressed respiration, and pinpoint pupils (miosis). Respiratory depression is the central life-threatening feature and the basis of the opioid toxidrome.

Definition

Opioid overdose is the toxic state produced when opioid agonism at central mu-opioid receptors exceeds tolerance, depressing the brainstem respiratory drive and level of consciousness, classically with miosis.

Scope

The entry describes opioid overdose as a clinical entity: its defining toxidrome, the receptor mechanism that produces respiratory depression, the role of the competitive antagonist naloxone in reversing it, and the public-health context of rising opioid-related deaths. It explains the entity for reference purposes and does not provide dosing or resuscitation instructions.

Core questions

• What clinical features define the opioid toxidrome?
• Why is respiratory depression the principal cause of harm?
• How does the antagonist naloxone reverse opioid effects, mechanistically?
• How have potent synthetic opioids changed the clinical and epidemiologic picture?

Key concepts

• Opioid toxidrome (CNS depression, respiratory depression, miosis)
• Mu-opioid receptor agonism
• Respiratory depression as the lethal mechanism
• Naloxone as a competitive opioid antagonist
• Synthetic opioids (fentanyl and analogues)
• Tolerance and re-narcotization

Mechanisms

Opioid agonists bind mu-opioid receptors in the central nervous system, reducing the respiratory centre's responsiveness to carbon dioxide and lowering consciousness, while also producing miosis; the resulting hypoventilation and hypoxia are the proximate cause of death in overdose. Naloxone is a competitive mu-opioid antagonist that displaces the agonist and can reverse respiratory depression; because its duration may be shorter than that of long-acting or high-potency opioids, opioid effects can recur after it wears off (Boyer 2012; Goldfrank 2019).

Clinical relevance

Opioid overdose is a leading cause of poisoning death and a defining example of a reversible toxidrome, making it central to understanding the link between a toxic mechanism and a specific antidote. This entry characterizes the entity and its mechanism for reference and is not a guide to diagnosing or treating an overdose in an individual.

Epidemiology

Opioid overdose has become a major cause of poisoning-related mortality in many countries, with the burden driven in successive waves by prescription opioids, heroin, and—more recently—illicitly manufactured high-potency synthetic opioids such as fentanyl analogues, which raise overdose risk (Boyer 2012).

History

Opioid poisoning has been recognized for as long as opium has been used medicinally, but its clinical framing as a discrete, antagonist-reversible toxidrome was consolidated in modern toxicology, and the entity gained renewed prominence with the surge in opioid-related deaths and the spread of potent synthetic opioids in the early twenty-first century (Boyer 2012).

Key figures

• Edward Boyer
• Lewis Goldfrank

Seminal works

• boyer-2012
• goldfrank-2019

Frequently asked questions

What is the classic clinical picture of opioid overdose?

The classic opioid toxidrome is the triad of depressed consciousness, slow or shallow breathing (respiratory depression), and pinpoint pupils (miosis); respiratory depression is the feature that makes overdose life-threatening.

Why can opioid effects return after naloxone?

Naloxone is a competitive antagonist with a duration of action that can be shorter than that of long-acting or high-potency opioids, so the agonist's effects—including respiratory depression—may recur once the antagonist wears off. This is described here for understanding, not as treatment advice.